AstraZeneca delivers 30{7d3485657e94c2a51293ca186d4450b2f27c317aa7ee3509dac6c8bbf5461118} more vaccines than expected to the European Union

upland-software-buys-bluevenn-for-52mn-to-boost-customer-engagement

European Commission President Ursula von der Leyen announced on Sunday that AstraZeneca will deliver nine million more doses than expected of its Covid vaccine to the EU in the first quarter, bringing the total to 40 million doses, an increase of 30{7d3485657e94c2a51293ca186d4450b2f27c317aa7ee3509dac6c8bbf5461118} corresponds.

The company, which has suffered the wrath of European leaders for several days due to major production delays, 'will start deliveries a week earlier than expected' and 'also expand its production capacity in Europe,' wrote von von. Leyen on Twitter.

The chairman, who spoke on Sunday with the CEOs of companies with which the EU has concluded vaccination contracts, also confirmed in an interview with the German broadcaster ZDF that the EU aims to vaccinate 70{7d3485657e94c2a51293ca186d4450b2f27c317aa7ee3509dac6c8bbf5461118} of adults by 'the end of summer'.

AstraZeneca, whose vaccine was approved for the European market on Friday, had announced a three-quarters reduction in shipments to the EU in the first quarter. AstraZeneca had claimed a 'drop in earnings' at a European manufacturing site to explain the delays in deliveries to the EU.
A statement classified as 'unsatisfactory' by the Commission calling for an inspection of the Belgian industrial site concerned, which was managed last Thursday by a subcontractor of the group.

In an interview with certain media, however, the CEO of AstraZeneca, the French Pascal Soriot, had assured that the British would have to reserve the production of factories in the United Kingdom. An argument strongly controversial by Brussels: Using British factories to supply the EU 'is not an option, but a contractual obligation,' emphasized a European official.

On Sunday, Berlin threatened legal action against laboratories 'that are failing to meet their obligations to deliver vaccines to the EU'. AstraZeneca signed a pre-order contract with Brussels in August for a total of 400 million cans, which the Commission published but cut many of the 'confidential' passages.

The company 'is determined to use all reasonable efforts to build capacity to produce 300 million doses of the vaccine without profit or loss,' states the text that mentions the option for the EU to grant an additional 100 million doses can order.